| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | Chief Executive Officer
2 companies
Mark T Iwicki is Director at PULM, with reported holdings spanning 2 companies. From April 2018 to October 2025, the filings on record show 1 open-market purchase and 13 sales. Mark T Iwicki's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $426K at current prices.
Our model assigns Mark T Iwicki a strong insider score of 76/100, based on 13 past trades. Over a 12-month horizon, 76.9% of those trades were profitable, with an average 12-month return of +44.3%.
Mark T Iwicki's largest disclosed position is in PULM as Director, worth about $408K. Net of sales, the PULM filings show accumulation of 307,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 | KALA Kala Bio, Inc. | Chief Executive Officer | Sell | 9,518 | $1.30 | $12,373.40 | -3.5% | +0.8% | -33.7% | |
| Oct 26, 2021 | KALA Kala Bio, Inc. | Chief Executive Officer | Sell | 27,598 | $1.80 | $49,676.40 | -9.3% | -51.8% | -93.0% | |
| Jun 28, 2021 | KALA Kala Bio, Inc. | Chief Executive Officer | Sell | 7,586 | $5.77 | $43,771.22 | -2.5% | -46.6% | -93.9% | |
| Apr 3, 2018 | PULM Pulmatrix, Inc. | Director | Buy | 307,000 | $0.00 | - | New | - | - |